Center for Biotechnology and Interdisciplinary Studies (CBIS)

Mothers of Children With Autism Found to Have Significantly Different Metabolite Levels

Blood sample analysis showed that, two to five years after they gave birth, mothers of children with autism spectrum disorder (ASD) had several significantly different metabolite levels compared to mothers of typically developing children. That’s according to new research recently published in BMC Pediatrics by a multidisciplinary team from Rensselaer Polytechnic Institute, Arizona State University, and the Mayo Clinic.

Bone Fracture Risk May Increase When Critical Enzymatic Processes Decline

TROY, N.Y. — A loss of enzymatic processes within the body can increase a person’s risk of bone fracture. This new insight was recently published in eLife by an international team of scientists and engineers led by Deepak Vashishth, the director of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute.

Ryan Gilbert and X. George Xu Elected Fellows of AIMBE

Ryan Gilbert, a professor of biomedical engineering at Rensselaer Polytechnic Institute, and X. George Xu, the Edward E. Hood Endowed Chair Professor Emeritus of mechanical, aerospace, and nuclear engineering, have been elected to the American Institute for Medical and Biological Engineering (AIMBE) 2021 class of fellows.

To Benefit Paralyzed Veterans, Polymer Coating Aims To Extend Life of Microelectrodes

For individuals with central nervous system paralysis, the effectiveness of neuroprosthetic technology — such as brain-controlled prosthetic limbs or muscle stimulation devices — makes a world of difference. If the process of implanting tiny electrodes in the brain were to be improved, allowing for stronger and longer lasting communication between neurons and external devices, it could significantly enhance quality of life.

New Research Aims To Combat Prion-like Spread of Tau Pathology in Alzheimer’s

Armed with evidence that a specific site on heparan sulfate — known as the 3-O-sulfate group — is critical to the transfer of harmful tau proteins in the brain, a research program funded by the NIH’s National Institute of Aging is scrutinizing the interactions between heparan sulfate and tau, determining how misfolded tau spreads in the brain, and developing strategies to block it.

Back to top